MicroTransponder, Inc.

About MicroTransponder, Inc.

MicroTransponder develops the Paired VNS platform, combining Vagus Nerve Stimulation (VNS) with therapy to improve the quality of life for patients with chronic neurological conditions, particularly focusing on helping stroke patients regain arm and hand motor function through their FDA-approved Vivistim System.

Products & Services

Vivistim Paired VNS™ System:An FDA-approved system designed to stimulate the vagus nerve during rehabilitation therapy to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment.

Specialties

Vagus Nerve Stimulation (VNS) Stroke Rehabilitation Neurological Condition Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series F T: - FT: Series F	A: 65000000 MR: - FA: 65 million FAN: 65000000	D: 2025-03-12 FD: 2025-03-12	8 investors

Series F Latest

2025-03-12

$65.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Richard Foust

Chief Executive Officer

N

Navzer Engineer

Co-Founder & Chief Scientific Officer

J

Jordan Curnes

Co-Founder & President

D

Doug Ellison

Chief Commercial Officer

B

Bunker Curnes

Chief Financial Officer

P

Prashant Rawat

Chief Operating Officer

View 19 more team members with Pro

Unlock Full Team Directory

Recent News